Lamisil Class Action Lawsuits Lamisil Class Action Lawsuits Information

Lamisil Class Action Lawsuits
Legal Information Home       |       Attorneys & Lawyers Directory       |       Legal Information Resources

Lamisil Class Action Lawsuits Information

Lamisil is a tablet medication for the treatment of onychomycosis, or nail fungus. The FDA issued a public health advisory warning physicians of the link between Lamisil and hepatic adverse events. The Lamisil risks include liver failure that can lead to death or liver transplant. Manufacturer Novartis Pharmaceuticals revised the labeling for Lamisil in the Warnings, Precautions, and Adverse Reactions sections.
The FDA received 16 reports of liver failure cases in Lamisil patients as of April 2001. In addition, prescribing errors have occurred instead of prescribing Lamisil patients have received Lamictal, an anti-epileptic.

Lamisil Side Effects

Lamisil side effects are very dangerous and deadly. The FDA found the Lamisil side effects to be so dangerous that a public health advisory warning was issued, in addition to Lamisil labeling changes. The FDA had received reports of liver failure in Lamisil patients, often leading to death.

There were 16 Lamisil side effects liver failure reports as of April 2001. When the Lamisil side effects warning was issued, healthcare professionals were sent letters alerting them of the reports of Lamisil liver failure, transplantation, and death. Physicians were recommended to take nail specimens for lab testing in potential Lamisil patients to reduce unnecessary risk of Lamisil side effects.

More Lamisil Information

Some patients suffering nail fungus may want to seek alternatives to Lamisil, particularly if running a high risk of suffering Lamisil side effects. There has been an increased risk of suffering Lamisil liver failure, transplantation, and death and some patients with preexisting conditions could better benefit from alternatives to Lamisil. An FDA public health advisory warning was issued after reports of liver failure and death had been made, and the FDA recommended physicians first take nail specimens for lab testing before determining if Lamisil will best suit the patient or if alternatives to Lamisil should be considered.

For more free legal information on known dangerous drugs and Class Action Lawsuits, please use the links below:

Free Legal Information Blog       |       Legal Articles       |       Free Legal Information